WO1997015827A9 - Capteur a fil enrobe - Google Patents
Capteur a fil enrobeInfo
- Publication number
- WO1997015827A9 WO1997015827A9 PCT/US1996/017893 US9617893W WO9715827A9 WO 1997015827 A9 WO1997015827 A9 WO 1997015827A9 US 9617893 W US9617893 W US 9617893W WO 9715827 A9 WO9715827 A9 WO 9715827A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sensor
- enzyme
- wire
- platinum wire
- platinum
- Prior art date
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 89
- 108090000790 Enzymes Proteins 0.000 claims abstract description 57
- 102000004190 Enzymes Human genes 0.000 claims abstract description 57
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 40
- 239000011248 coating agent Substances 0.000 claims abstract description 18
- 238000000576 coating method Methods 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 17
- 238000009413 insulation Methods 0.000 claims abstract description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002245 particle Substances 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 9
- -1 polytetrafluoroethylene Polymers 0.000 claims description 39
- 229920000642 polymer Polymers 0.000 claims description 18
- 229920002301 Cellulose acetate Polymers 0.000 claims description 16
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 16
- 239000004800 polyvinyl chloride Substances 0.000 claims description 16
- 229920000260 silastic Polymers 0.000 claims description 14
- 239000004814 polyurethane Substances 0.000 claims description 12
- 229920000557 Nafion® Polymers 0.000 claims description 11
- 229920002635 polyurethane Polymers 0.000 claims description 10
- WZCQRUWWHSTZEM-UHFFFAOYSA-N M-Phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 claims description 7
- GEYOCULIXLDCMW-UHFFFAOYSA-N O-Phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 239000004417 polycarbonate Substances 0.000 claims description 7
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 229920000515 polycarbonate Polymers 0.000 claims description 5
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 229960002897 Heparin Drugs 0.000 claims description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 230000004044 response Effects 0.000 description 47
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 42
- 239000008103 glucose Substances 0.000 description 42
- 229940088598 Enzyme Drugs 0.000 description 40
- 230000035945 sensitivity Effects 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 210000002381 Plasma Anatomy 0.000 description 17
- 239000010408 film Substances 0.000 description 16
- 239000002322 conducting polymer Substances 0.000 description 14
- 229920001940 conductive polymer Polymers 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 230000003247 decreasing Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 206010049771 Shock haemorrhagic Diseases 0.000 description 9
- 239000007853 buffer solution Substances 0.000 description 8
- 239000010410 layer Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 6
- 235000019420 glucose oxidase Nutrition 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 5
- 108010015776 EC 1.1.3.4 Proteins 0.000 description 4
- 229940116332 GLUCOSE OXIDASE Drugs 0.000 description 4
- 239000004366 Glucose oxidase Substances 0.000 description 4
- 241000282320 Panthera leo Species 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M Silver chloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000003345 hyperglycaemic Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 229920005597 polymer membrane Polymers 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Trioxopurine Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- 238000004164 analytical calibration Methods 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 230000002218 hypoglycaemic Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000001603 reducing Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002588 toxic Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 229940022659 Acetaminophen Drugs 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N Ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 229940116269 Uric Acid Drugs 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000002429 anti-coagulation Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000006056 electrooxidation reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 229920000554 ionomer Polymers 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- GJFIEPAJMYPAGC-UHFFFAOYSA-N 1,1'-dimethylferrocene Chemical compound C12C3C4C5(C)C2[Fe]45245631C1C6C5C4C21C GJFIEPAJMYPAGC-UHFFFAOYSA-N 0.000 description 1
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical compound CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 description 1
- 229940072107 Ascorbate Drugs 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N Dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 description 1
- 229940093818 Dicumarol Drugs 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N HCl HCl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- GUWSLQUAAYEZAF-UHFFFAOYSA-L Lead(II) acetate Chemical compound O1C(C)=O[Pb]21O=C(C)O2 GUWSLQUAAYEZAF-UHFFFAOYSA-L 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl 2-cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 240000004375 Petrea volubilis Species 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- QGFSULIVEYGQQY-UHFFFAOYSA-H Sodium hexachloroplatinate Chemical compound [Na+].[Na+].Cl[Pt-2](Cl)(Cl)(Cl)(Cl)Cl QGFSULIVEYGQQY-UHFFFAOYSA-H 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000024881 catalytic activity Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 230000001808 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960001912 dicoumarol Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000004401 flow injection analysis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 238000011068 load Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000001590 oxidative Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Definitions
- the present invention relates to a coated wire sensor, which can be used in the laboratory, has clinical applications, has applications in the food and pharmaceutical industries, and in particular can be used in the management of hemorrhagic shock.
- a coated wire sensor can be used to increase the survival rate of injured patients who are at risk of hemorrhagic shock, especially while they are being transported to a hospital .
- the important point in such an application is that unlike diabetes, hemorrhagic shock requires direct intravascular implantation of such sensors, and the monitoring of glucose levels for up to several hours.
- hemorrhagic shock is characterized by the alteration of the glucose concentrations between the hypoglycemic and hyperglycemic levels.
- a linearity of the sensor signal versus the glucose concentration is required. This linearity should be at least 22 mM (400 mg/dL) to assure linear output of the sensor within a safety margin.
- the heretofore known devices do not provide for a high enough linearity.
- Electropolymerization involves the electrochemical oxidation of a monomer from a solution containing the enzyme to form a conducting or non-conducting polymer on the electrode surface. This approach has several advantages. First, this process can be governed by the electrode potential, and therefore allows accurate control of the polymer film thickness and hence the amount of entrapped enzyme. Second, since the polymerization occurs locally at the electrode surface, it can be used to confine an enzyme precisely at the electrode without cross-immobilizing it on a neighboring electrode. This property is suitable for the fabrication of micro-arrays. Third, it is possible to use this technique for building multilayer structures, either one or more enzymes layered within a single polymer, or one enzyme within a multilayered copolymer.
- Foulds et al also demonstrated the possible use of covalently attached ferrocenes to pyrrole monomers as a step towards the fabrication of reagentless sensors (N.C Foulds and CR. Lowe, Anal. Chem., 60 (1988) 2473) .
- mediators in pyrrole films as anionic counter ions (Y. Kajiya, H. Sugai, C Iwakura and H. Yoneyama, Anal. Chem., 63 (1991 49; S. Yabuki, H. Shinohara, Y. Ikariyama and M. Aizawa, J. Electroanal . Chem. 277 (1990) 179) .
- Non-conducting polymers have been studied as they have several advantageous characteristics not found in the conducting polymers. First, their growth is self limiting, thus producing thin polymer films. This results in a short sensor response time. The thin film also allows a higher enzyme content leading to a large sensor response and a high sensitivity. Non-conducting polymers also have a characteristic permselectivity, greatly decreasing the effect of common physiological interferents on the sensor response.
- a non-conducting polymer that has been the focus of much research is 1, 2-phenylenediamine.
- Sasso et al proposed a glucose sensor having a platinized reticulated vitreous carbon electrode with GOD entrapped in a poly(1, 2-phenylenediamine) film (S.V. Sasso, R.J. Pierce, R. Walla, and A.M. Yacynych, Anal. Chem., 62 (1990) 1111) . Their sensor was used in Flow Injection Analysis for determining glucose levels in human serum. They demonstrated the ability of the poly (1, 2-phenylenediamine) film in increasing the thermal stability of the GOD enzyme.
- Malitesta et al constructed a glucose sensor, employing the same principle, but using platinum electrodes (C Malitesta, F. Palmisano, L.
- poly(1, 3-phenylenediamine) Another non-conducting polymer that has been studied is poly(1, 3-phenylenediamine) .
- This polymer is not commonly used in the construction of glucose sensors although it possesses the same p e r m s e l e c t i v e p r o p e r t i e s a s poly(1, 2-phenylenediamine) .
- Geise et al . have demonstrated the use of 1, 1' -dimethylferrocene as a mediator entrapped with GOD in a poly(1, 3-phenylenediamine) film (R.J. Geise, S.Y. Roach and A.M. Yacynych, Anal. Chim.
- Fig. 1 is a cross-sectional view of a first exemplary embodiment of the inventive coated wire sensor
- Fig. 2 is a cross-sectional view of a second exemplary embodiment of an inventive coated wire sensor
- Fig. 3 shows a third exemplary embodiment of an inventive coated wire sensor. Disclosure of the Invention
- the coated wire sensor of the present invention is characterized primarily by: a platinum wire as a working electrode, a sensor body in the form of a hollow member disposed about at least a portion of the platinum wire, with the sensor body being spaced from the wire, a reference electrode that is operatively associated with a first end of the platinum wire but is not in contact with the wire, insulation disposed along at least a portion of the length of the platinum wire between the wire and the sensor body and/or the reference electrode, enzyme-containing material disposed on the first end of the platinum wire, with this enzyme-containing material comprising enzyme chemically linked to fine carbon particles, and a coating disposed over the enzyme- containing material.
- the inventive electrode has a Pt base electrode surface.
- Others use a carbon based electrode surface with a platinized surface - platinium hexachloride particles - a carbon ultramicroelectrode, using carbon fibers. We do not use a mediator. If a mediator is used, then a Pt surface is not needed.
- the inventive electrode uses fine carbon particles plus Nafion, with the enzyme chemically bound (immobilized, linked to) the surface of the particles.
- the inventive electrode has a very large effective surface area. This allows there to be an excess of enzyme in the pool, over that entrapped in the Nafion or the electrodeposited layer. Therefore, the inventive electrode function is independent of the degree of inactivation of the enzyme.
- the inventive electrode works in a diffusion-limited mode, the activity of the electrode depends on the properties of the membranes employed, not on the degree of inactivation of the enzyme. Others use free enzyme above the base electrode, and sometimes an electron transfer mediator (such as ferrocene, resorcinol) . Construction of their electrodes suggests that their electrodes function in a kinetic regime.
- the inventive electrode operates at an applied voltage (bias) of 0.65V. Others use a different bias, operating their electrode in a different electrochemical regime. 5.
- the inventive electrode incorporates into the layer on top of the Pt base electrode, a Nafion ionomer to stabilize the sensor and decrease interference. Further, it makes the electrode function in a diffusion-limited mode, and also avoids many interference effects from external body chemicals or chemicals from an industrial process.
- the inventive electrode has coatings applied on the outside of one or more of PVC, polyurethane, cellulose acetate, silastic This protects the internal enzymes from external interfering chemicals and fluids.
- the inventive signal is, compared to others, very large, stable, and noise free.
- the inventive sensor lifetime is up to 56 days, others achieve at best a few days.
- the inventive sensor response time is a few seconds to a minute, others are 2 minutes or more.
- the inventive sensors have a linear range up to 30 mM glucose in blood, others have only a linear range up to about 6-8 mM in buffers, with the use of toxic mediators. Other sensors cannot be used as implantable glucose sensors in humans, as they funtion and respond properly only over the normal to normal-high range of glucose concentration, not into the hyperglycemic range.
- the inventive sensors responded in blood and plasma up to 38 mM glucose. Others had responses up to maybe 20 mM before the response flattens, and only with the use of toxic mediators (such as resorcinol, ferrocene etc) , undesirable in patients in shock.
- toxic mediators such as resorcinol, ferrocene etc
- Fig. 1 shows an inventive sensor that was fabricated by entrapping the glucose oxidase enzyme in an electrochemically grown poly(1,3- phenylenediamine) film.
- This sensor which is, for example, a needle glucose biosensor, has a working electrode or anode in the form of the platinum wire 1. Except for the end 1' , the platinum wire 1 is covered by insulation 2, such as Silastic. Surrounding the insulation 2 is a sensor body 3, which in this embodiment is in the form of a stainless steel needle. Disposed on the exposed bulb end 1' of the platinum wire 1 is enzyme-containing material, in this embodiment in the form of enzyme incorporated in poly(1,3- phenylenediamine) film. A polymer coating 5 is then disposed over the enzyme-containing material 4. Finally, a reference electrode or cathode 6 is connected to the sensor body or needle 3.
- a portion of a platinum wire working electrode IA is again covered with an insulation 2A, such as Silastic, leaving exposed one end of the wire 1.
- the sensor body or stainless steel needle 3A is disposed on the insulation 2A and in this embodiment extends not only beyond the insulation but also beyond the exposed end l'A of the wire IA.
- the enzyme-containing material 4A that is disposed over the end l'A is in this embodiment enzyme incorporated in a platinum black matrix.
- a coating 5A for example, Nafion.
- a reference electrode or cathode 6A is again connected to the needle 3A.
- Fig. 3 shows a modified embodiment that can be used in the laboratory and for clinical applications.
- the platinum wire IB has a portion thereof, except for the bulb-like end l'B, covered by insulation 2B in the form of a heat shrunk tube.
- insulation 2B in the form of a heat shrunk tube.
- a sensor body 3B Disposed about part of the insulation 2B is a sensor body 3B in the form of an outer wrapping that is preferably made of plastic, although it could also be made of some other material, such as metal.
- a reference electrode or cathode 6B extends between the insulation 2B and the sensor body 3B and is wrapped around the insulation 2B between the bulb ⁇ like end l'B of the platinum wire and the sensor body 3B.
- the enzyme- containing material 4B comprises a conducting or non-conducting polymer.
- Conducting and nonconducting polymers that can be used include, but are not limited to conducting polymers such as poly(pyrrole) , poly (N-methylpyrrole) (P.N. Bartlett and P.G. Whittaker, J. Electroanal. Chem., 224 (1987) 37) , poly(aniline) (J.C Cooper and E.A.H. Hall, Biosensors, 7 (1992) 473) ; nonconduct ing polymers such as poly ( l , 2 -phenylenediamine ) and poly(1, 3-phenylenediamine) , poly- (phenol) (J. Wang, S-P Chen and M-S Lin, J. Electroanal. Chem., 273 (1989) 231; R.L.
- conducting polymers such as poly(pyrrole) , poly (N-methylpyrrole) (P.N. Bartlett and P.G. Whittaker, J. Electroanal. Chem., 224 (1987) 37) , poly
- Polymer membranes that can be used for the coating 5, as well as the insulation 2 include, for example, polyurethane, polyvinylchloride, Silastic, and cellulose acetate, polytetrafluoroethylene, polycarbonate.
- the design approach for fabrication of the sensor was chosen to be that of miniaturization to a needle size.
- a hypodermic needle approximately 18 gauge -- outer diameter 1.27 mm was chosen to act as sensor body and as counter and reference electrodes .
- three different methods of enzyme immobilization were chosen and investigated, leading to 3 different prototypes.
- the fabrication of the sensors involved three principal steps.
- the first step which is common to the three sensor designs, involves the initial pretreatment and preparation of the needle body and the platinum electrode.
- the second step is the immobilization of the glucose oxidase enzyme and its incorporation into the needle body.
- the third and last step is the formation of the diffusion limiting membrane or coating. The coatings differ according to each immobilization technique.
- the initial preparation and pretreatment of the sensor body and platinum wires were as follows.
- the stainless steel needle was cut at both ends to remove the plastic cap and the pointed end, and the ends were smoothed using files and fine sand paper.
- the needle was cleaned in concentrated nitric acid, washed with distilled water and dried.
- a platinum wire was cleaned in concentrated nitric acid and treated in a propane flame to form a smooth shape or a bulb at one of the ends.
- the platinum wire was insulated by dipping in Silastic up to 2 mm below the bulb end, or by sealing in a polyethylene tubing with proper inner diameter and was fixed in place by gluing to the sensor body with cyanoacrylate glue. Wires of 0.5 mm diameter were insulated using Teflon heat shrinkable tubing.
- the partially insulated platinum wire was electrochemically treated by switching between +2.0 V and -1.0 V versus a silver/silver chloride electrode in a three electrode scheme six times for one hour.
- Figure 1 shows a schematic of a sensor fabricated by entrapping the GOD enzyme in an electrochemicallygrownpoly(1, 3-phenylenediamine) film.
- the electropolymerization of 1, 3-phenylenediamine and the incorporation of the enzyme particles was carried out in a solution containing 3-5 mg of 1, 3-phenylenediamine, 20 mg of Glucose Oxidase and 20 mg of ULTI carbon powder in 9 mL at pH 7.4 and 1 mL of Nafion.
- This preparation process was performed potentiostatically at +0.65 V versus a silver/silver chloride reference electrode for 15 minutes.
- An additional coating of poly(1, 3-phenylenediamine) was carried out. The formation of this coating was in a solution of 3-5 mg of 1, 3-phenylenediamine .
- This process was performed potentiostatically at +0.65 V versus a silver/silver chloride reference electrode for 10 minutes.
- the prepared platinum electrode was washed thoroughly in a stirred buffer solution overnight .
- a variety of different polymer membranes of varying concentrations were applied to this sensor. The membranes were formed over the sensor tip by dip casting. The sensor end was dipped in the polymer solution for 20 seconds. The sensor was then held vertically and dried in air for one hour. The results of evaluation tests on the above manufactured sensors are given below.
- Figure 2 shows a schematic of a sensor fabricated by entrapping the GOD enzyme in a platinum black matrix.
- the platinization and electrophoretic incorporation of the enzyme particles was carried out in a solution containing 33 mg of sodium hexachloroplatinate and 30 mg of Glucose Oxidase and 0.6 mg of lead acetate in one mL at pH 3.5 (Y.
- Nafion coatings of the sensor were obtained by dipping the sensor end in 0.5% ionomer solution for 30 seconds. The sensor was then held vertically and dried in air for one hour.
- Fig. 3 shows the schematic of the electrode construction.
- the electrode consists of a platinum wire, a coating layer of St ⁇ ber glass beads on the platinum, and the outer immobilized enzyme layer.
- the glass coating layer has two effects: it acts as a support and matrix for the enzyme; it can be a barrier to some substances that may cause disturbance in the signal.
- Silanization was utilized to prepare the St ⁇ ber glass beads and the platinum wire surfaces to bond with glutaraldehyde.
- a solution of 3- aminopropytriethoxy silane (0.2 mL) in distilled water (2 mL, to give a 10% v/v solution) was prepared.
- the pH was adjusted to 4.1 using hydrochloric acid (HCl) solution.
- This mixture was subsequently placed into a small vial and several electrode immersed into the vial . They were kept in an oven at 80°C and shaken every fifteen minutes for three hours.
- the sensors were rinsed completely in distilled water and then dried at 120°C for three hours.
- the wires were stored in the refrigerator for 24 hours.
- Immobilization was accomplished by first creating a layer of glutaraldehyde bonded to the silanized electrode surface.
- a 2.5% glutaraldehyde solution was made with 27 mL distilled water and 3 mL of 25% glutaraldehyde.
- Immobilization was accomplished by immersing the wire in the glutaraldehyde solution, continuously stirred, for one hour at room temperature. The wires were then rinsed with water for one hour at room temperature, after which the electrodes were immersed in the enzyme solution.
- the enzyme solution was prepared with 80 mg of glucose oxidase in 2 mL phosphate buffer of pH 7.4. The wires were left in the enzyme solution overnight at 4°C to allow immobilization onto the glass layer.
- Table 1 shows a summary of the sensor characteristics obtained with sensors employing five different polymer coatings, namely; cellulose acetate (CA) , Silastic 3-5025, Silastic Q7-2213, polyurethane (PU) and polyvinylchloride (PVC) .
- Table 1 presents a variety of concentrations of the polymer coating solutions and the resulting parameters of the calibration curves of the sensors: linearity (as the upper limit of the calibration curve linear range) , sensitivity (slope of the linear portion of the calibration curve) and response time. It should be noted that any coated sensors showing a non-linear response were assumed to have a linear range of 2.2 mM as the linearity below this range was not investigated.
- Table 2 shows the evaluation of the second prototype sensor performance in plasma and in buffer solution before and after the plasma test. Comparing the sensor response in buffer solution before the plasma test with that during the plasma test, it can be seen that the values of the sensor response to glucose concentration from 10 to 12 mM in both measurements coincide (within 2%) . At higher glucose concentration the signal in plasma is lower than that obtained in buffer solution but with an acceptable deviation of 7%. A higher response of the sensor to glucose levels in plasma within the range 4.4 - 8.4 mM is observed. The values of the sensor response obtained in buffer after the plasma test practically coincide with those obtained in plasma.
- the effect of interferents was tested by five common substances.
- the first sensor prototype shows a decrease in sensitivity after the addition of interferents.
- the second sensor prototype shows a decreased effect of glycine, urea and ascorbic
- Hemorrhagic shock is characterized by the alteration of glucose concentrations between the hypoglycemic and hyperglycemic levels.
- the sensor response should be linear in glucose concentration over the range of interest. This linearity should be at least 22 mM (400 mg/dL) to assure linear output of the sensor within some safety margin. It can be seen from Table 4 that all sensor prototypes satisfy this requirement . The linearity of the sensor output signal versus the glucose concentration is extended to at least 22 mM.
- the first sensor prototype showed a linearity of 26.7 mM with sensitivity of 1.62 nA/mM, 31.1 mM with a sensitivity of 1.35 nA/mM, and 37.7 mM with a sensitivity of 1.8 nA/mM for cellulose acetate (CA) , polyurethane (PU) and polyvinylchloride (PVC) coated sensors, respectively.
- the second sensor prototype (with enzyme entrapped in a platinum black matrix) showed a linearity of up to 33 mM.
- the third sensor prototype also showed a linearity of at least 22 mM. Another requirement for monitoring glucose levels during hemorrhagic shock is a fast sensor response (short response time) to changes in glucose concentration.
- the first sensor prototype shows response times of 183, 24 and 35 seconds for CA, PU and PVC coated sensors, 5 while the second sensor prototype shows a response time of 60 seconds; the third prototype shows a resonse time of 90 seconds.
- Another test reflecting the response times of the sensors is the in vitro hemorrhagic shock simulation test.
- the second sensor prototype shows a response time of 5 minutes for the increasing and 10 minutes for the decreasing step changes. It is
- the first and second sensor prototypes show the shortest response times in response to both small and large changes in glucose concentration.
- Plasma Test Decreased Decreased No change in sensit ivity Sensit ivity Sensitivity
- the reproducibility of the sensor signal 35 is good in all three sensor prototypes.
- the variations in the sensor response do not exceed 5% in the first prototype response, while it is less than 10% for the second prototype.
- All three prototypes showed a life time 40 of at least one week with no significant change in the sensor performance, hence satisfying the life time requirement .
- One last aspect to be considered is the ease of fabrication of the sensor prototypes. In general, the three sensor prototypes are easily fabricated. The first prototype has the advantage of electrochemical growth of the entrapping film, hence allowing better controllability on the thickness of the film and hence the amount of enzyme entrapped.
Abstract
Ce capteur à fil enrobé comprend un fil de platine (1) en guise d'électrode opérationnelle, un corps (3) de capteur, creux et disposé autour d'au moins une partie du fil de platine, fil dont il est séparé, une électrode de référence (6) associée opérationnellment avec une première extrémité du fil de platine mais sans entrer en contact avec ce fil, une isolation (2) disposée au moins le long d'une partie du fil de platine entre celui-ci et le corps de capteur et/ou l'électrode de référence, une substance (4) contenant une enzyme, disposée à la première extrémité du fil de platine et contenant une enzyme liée chimiquement à de fines particules de carbone, ainsi qu'un enrobage (5) disposé sur cette substance contenant une enzyme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54781495A | 1995-10-25 | 1995-10-25 | |
US08/547,814 | 1995-10-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997015827A1 WO1997015827A1 (fr) | 1997-05-01 |
WO1997015827A9 true WO1997015827A9 (fr) | 1997-11-13 |
Family
ID=24186238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/017893 WO1997015827A1 (fr) | 1995-10-25 | 1996-10-25 | Capteur a fil enrobe |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1997015827A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3398598B2 (ja) * | 1998-06-10 | 2003-04-21 | 松下電器産業株式会社 | 基質の定量法ならびにそれに用いる分析素子および測定器 |
AU1631101A (en) * | 1999-10-07 | 2001-05-10 | Pepex Biomedical, Llc | Sensor for measuring a bioanalyte such as lactate |
DE10015818A1 (de) | 2000-03-30 | 2001-10-18 | Infineon Technologies Ag | Biosensor und Verfahren zum Ermitteln makromolekularer Biopolymere mit einem Biosensor |
DE10015816A1 (de) * | 2000-03-30 | 2001-10-18 | Infineon Technologies Ag | Biosensorchip |
DE10032042A1 (de) * | 2000-07-05 | 2002-01-24 | Inventus Biotec Gesellschaft Fuer Innovative Bioanalytik, Biosensoren Und Diagnostika Mbh & Co. Kg | Elektrochemischer Einwegbiosensor für die quantitative Bestimmung von Analytkonzentrationen in Flüssigkeiten |
DE10119036C1 (de) | 2001-04-18 | 2002-12-12 | Disetronic Licensing Ag | Tauchsensor zur Messung der Konzentration eines Analyten mit Hilfe einer Oxidase |
US6872297B2 (en) | 2001-05-31 | 2005-03-29 | Instrumentation Laboratory Company | Analytical instruments, biosensors and methods thereof |
US6652720B1 (en) * | 2001-05-31 | 2003-11-25 | Instrumentation Laboratory Company | Analytical instruments, biosensors and methods thereof |
AU2006252048B2 (en) * | 2001-05-31 | 2008-09-04 | Instrumentation Laboratory Company | Analytical instruments and biosensors, and methods for increasing their accuracy and effective life |
US6960466B2 (en) | 2001-05-31 | 2005-11-01 | Instrumentation Laboratory Company | Composite membrane containing a cross-linked enzyme matrix for a biosensor |
US6501976B1 (en) * | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
WO2009051901A2 (fr) | 2007-08-30 | 2009-04-23 | Pepex Biomedical, Llc | Capteur électrochimique et procédé de fabrication |
WO2009032760A2 (fr) | 2007-08-30 | 2009-03-12 | Pepex Biomedical Llc | Capteur électrochimique et procédé de fabrication |
US8951377B2 (en) | 2008-11-14 | 2015-02-10 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor module |
US9445755B2 (en) | 2008-11-14 | 2016-09-20 | Pepex Biomedical, Llc | Electrochemical sensor module |
US9585605B2 (en) | 2011-05-19 | 2017-03-07 | Pepex Biomedical, Inc. | Fluid management and patient monitoring system |
WO2012162151A2 (fr) | 2011-05-20 | 2012-11-29 | Pepex Biomedical, Inc. | Fabrication de modules de détection électrochimique |
CN104918551B (zh) | 2012-12-03 | 2019-07-26 | Pepex生物医药有限公司 | 传感器模块以及使用传感器模块的方法 |
US9594047B2 (en) * | 2013-04-26 | 2017-03-14 | Universiteit Antwerpen | Potentiometric sensors and method for measuring intermolecular interactions |
CN107003264B (zh) | 2014-06-04 | 2020-02-21 | 普佩克斯生物医药有限公司 | 电化学传感器和使用先进印刷技术制造电化学传感器的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3700119A1 (de) * | 1987-01-03 | 1988-07-14 | Inst Diabetestechnologie Gemei | Implantierbarer elektrochemischer sensor |
FR2630546B1 (fr) * | 1988-04-20 | 1993-07-30 | Centre Nat Rech Scient | Electrode enzymatique et son procede de preparation |
US5089112A (en) * | 1989-03-20 | 1992-02-18 | Associated Universities, Inc. | Electrochemical biosensor based on immobilized enzymes and redox polymers |
-
1996
- 1996-10-25 WO PCT/US1996/017893 patent/WO1997015827A1/fr active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997015827A9 (fr) | Capteur a fil enrobe | |
WO1997015827A1 (fr) | Capteur a fil enrobe | |
Moussy et al. | In vitro and in vivo performance and lifetime of perfluorinated ionomer-coated glucose sensors after high-temperature curing | |
US4894253A (en) | Method for production of coated electrode | |
US5286364A (en) | Surface-modified electochemical biosensor | |
US6268161B1 (en) | Biosensor | |
JP3194434B2 (ja) | 植込み可能なグルコースセンサー | |
US9237865B2 (en) | Analyte sensors and methods for making and using them | |
US6413396B1 (en) | Enzyme electrode sensor and manufacturing method thereof | |
US5914026A (en) | Implantable sensor employing an auxiliary electrode | |
Mădăraş et al. | Microfabricated amperometric creatine and creatinine biosensors | |
CA1212146A (fr) | Capteur - doseur de melanges liquides | |
US9439585B2 (en) | Semiconductor based analyte sensors and methods | |
Vaidya et al. | Effect of interference on the performance of glucose enzyme electrodes using Nafion® coatings | |
CA2578227A1 (fr) | Membrane polymere amelioree par resine epoxyde, pour augmenter la longevite de capteurs biologiques | |
JP2001506365A (ja) | グルコースセンサー | |
JPH021536A (ja) | 膜被履センサ | |
Wang et al. | One-step electropolymeric co-immobilization of glucose oxidase and heparin for amperometric biosensing of glucose | |
Yang et al. | An Integrated Needle‐Type Biosensor for Intravascular Glucose and Lactate Monitoring | |
Abdel-Hamid et al. | Development of a needle-type biosensor for intravascular glucose monitoring | |
JP4185423B2 (ja) | 電気化学バイオセンサの製造方法 | |
Campanella et al. | Enzyme-entrapping membranes for enzyme sensors | |
Yang et al. | Enzyme electrodes with glucose oxidase immobilized on Stöber glass beads | |
JP3447374B2 (ja) | 酵素センサーおよびその製造方法 | |
JPS63159748A (ja) | 分析物質を測定するための酵素−電極型センサ、このセンサの製法および試料中の分析物質を測定する方法 |